Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-3
pubmed:dateCreated
2006-7-24
pubmed:abstractText
It has been reported that a prior exposure of isoflurane, a commonly used volatile anesthetic in clinical practice, reduces brain cell death after ischemia. This isoflurane preconditioning-induced neuroprotection has been shown in rat in vivo and in vitro brain ischemia models. To investigate the mechanisms of this protection, we used the human neuroblastoma SH-SY5Y cells and simulated ischemia in vitro by oxygen-glucose deprivation. We found that isoflurane exposure for 30 min at 24 h before a 5-h oxygen-glucose deprivation dose-dependently reduced cell death. Isoflurane exposure induced phosphorylation/activation of extracellular signal-regulated kinase (ERK). Inhibition of the phospho-ERK expression abolished the isoflurane preconditioning-induced protection. Isoflurane exposure also increased the expression of early growth response gene 1 (Egr-1) and Bcl-2, proteins downstream of ERK. Egr-1 is a transcription factor and plays a role in cell survival. Bcl-2 is an anti-apoptotic protein. The increased expression of Egr-1 and Bcl-2 by isoflurane was inhibited by ERK inhibition. Thus, our results suggest a role of ERK/Egr-1/Bcl-2 pathway in the isoflurane preconditioning-induced protection in the human neuroblastoma SH-SY5Y cells.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0014-2999
pubmed:author
pubmed:issnType
Print
pubmed:day
7
pubmed:volume
542
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
84-91
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:16806162-Butadienes, pubmed-meshheading:16806162-Cell Hypoxia, pubmed-meshheading:16806162-Cell Line, Tumor, pubmed-meshheading:16806162-Cell Survival, pubmed-meshheading:16806162-DNA, Single-Stranded, pubmed-meshheading:16806162-Dose-Response Relationship, Drug, pubmed-meshheading:16806162-Enzyme Inhibitors, pubmed-meshheading:16806162-Extracellular Signal-Regulated MAP Kinases, pubmed-meshheading:16806162-Glucose, pubmed-meshheading:16806162-Humans, pubmed-meshheading:16806162-Hypoxia-Ischemia, Brain, pubmed-meshheading:16806162-Isoflurane, pubmed-meshheading:16806162-Neuroblastoma, pubmed-meshheading:16806162-Neuroprotective Agents, pubmed-meshheading:16806162-Nitriles, pubmed-meshheading:16806162-Proto-Oncogene Proteins c-bcl-2, pubmed-meshheading:16806162-Reperfusion Injury, pubmed-meshheading:16806162-Signal Transduction
pubmed:year
2006
pubmed:articleTitle
Isoflurane preconditioning protects human neuroblastoma SH-SY5Y cells against in vitro simulated ischemia-reperfusion through the activation of extracellular signal-regulated kinases pathway.
pubmed:affiliation
Department of Anesthesiology and Neuroscience, University of Virginia, Charlottesville, VA 22908, USA. zz3c@virginia.edu
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural